• No results found

Syncope: Classification and risk stratification

N/A
N/A
Protected

Academic year: 2021

Share "Syncope: Classification and risk stratification"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

(1)

ContentslistsavailableatScienceDirect

Journal

of

Cardiology

j ou rn a l h o m ep a g e :w w w . e l s e v i e r . c o m / l o c a t e / j j c c

Review

Syncope:

Classification

and

risk

stratification

Venkata

Krishna

Puppala

(MD),

Oana

Dickinson

(MD),

David

G.

Benditt

(MD)

∗ TheCardiacArrhythmiaCenter,UniversityofMinnesotaMedicalSchool,Minneapolis,MN,USA

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received19March2013 Accepted22March2013 Availableonline7January2014

Keywords:

Syncope Riskstratification

Transientlossofconsciousness Syncopeclinic

a

b

s

t

r

a

c

t

Background:Syncopeisoneofthemostcommonreasonsforemergencydepartmentandurgentcare

clinicvisits.Themanagementofsyncopecontinuestobeachallengingproblemforfront-lineproviders inasmuchasthereareamultitudeofpossiblecausesforsyncoperangingfromrelativelybenignconditions topotentiallylife-threateningones.Inanyevent,itisimportanttoidentifythosesyncopepatientswho areatimmediateriskoflife-threateningevents;theseindividualsrequireprompthospitalizationand thoroughevaluation.Conversely,itisequallyimportanttoavoidunnecessaryhospitalizationoflow-risk patientssinceunneededhospitalcareaddstothehealthcarecostburden.

Results:Historically,front-lineprovidershavetakenaconservativeapproachwithadmissionratesashigh

as30–50%amongsyncopepatients.Anumberofstudiesevaluatingboththeshort-andlong-termrisk ofadverseeventsinpatientswithsyncopehavefocusedondevelopmentofrisk-stratificationguidelines toassistprovidersinmakingaconfidentandwell-informedchoicebetweenhospitalizationand out-patientreferral.Inthisregard,amuchneededconsensusonoptimaldecision-makingprocesshasnot beendevelopedtodate.However,knowledgefromvariousavailablerisk-stratificationstudiescanbe helpful.

Conclusion:Thisreviewsummarizesthefindingsofvariousrisk-stratificationstudiesandpointsout

keydifferencesbetweenthem.While,theexistingrisk-stratificationmethodscannotreplacecritical assessmentbyanexperiencedphysician,theydoprovidevaluableguidance.Inaddition,thevarious risk-assessmentschemeshighlighttheneedforcarefulinitialclinicalassessmentofsyncopepatients, selectivetesting,andbeingmindfuloftheshort-andlong-termrisks.

©2014JapaneseCollegeofCardiology.PublishedbyElsevierLtd.Allrightsreserved.

Contents

Introduction... 172

Classificationofsyncope... 172

Neurally-mediatedsyncope(alsotermedneuralreflexsyncope)... 172

Orthostatichypotension ... 172

Syncopeduetocardiacarrhythmias... 172

Syncopeduetostructuralcardiacdisease... 173

Syncopesecondarytocerebrovascularcauses... 173

Syncopemimics... 173

Riskstratificationofsyncope... 173

Short-termorimmediaterisk... 174

High-riskmarkersofshort-termadverseoutcomes... 175

Long-termrisk... 175

Riskstratificationbasedoncardiacversusnon-cardiaccausesofsyncope... 175

Issyncopeamarkerofincreasedriskofcardiovascularmorbidityandmortality?... 176

Conclusion... 176

Acknowledgment... 176

References... 177

∗Correspondingauthorat:TheCardiacArrhythmiaCenter,UniversityofMinnesotaMedicalSchool,MMC508,420DelawareStreetSE,Minneapolis,MN55455,USA. Tel.:+16126254401;fax:+16126244937.

E-mailaddress:[email protected](D.G.Benditt).

0914-5087/$–seefrontmatter©2014JapaneseCollegeofCardiology.PublishedbyElsevierLtd.Allrightsreserved.

(2)

Introduction

Syncopeisasyndromecharacterizedbyatransientself-limited episodeoflossofconsciousnessoccurringasaresultofabrief inter-ruptionofoxygensupplytothebrain.Thisinterruptionofcerebral nutrientflowinasyncopaleventisalmostalwaysduetotransient cessationofblood flow[1,2].Atransientreversibledropin sys-temicarterialbloodpressuretoalevelbelowthatneededtosustain cerebralperfusionisthemostcommoncauseofsyncope.Other possibilitiesarerare,and includeacutehypoxemia (e.g.aircraft decompression)ormajormetabolicdisturbanceaffectingneuronal pathways.

Sincetransientglobalcerebralhypoperfusionisthesinequanon ofsyncopepathophysiology,othercausesoflossofconsciousness shouldnotbeclassifiedas‘syncope’.Thusseizures,concussions, hypoglycemia,andothernon-perfusionrelateddisturbancesare separatediagnosticissues;thesearenon-syncopecausesof tran-sientlossofconsciousness(TLOC)[1,3].

Intruesyncope,theepisodeischaracterizedbyarapidonset oflossofconsciousnesswithorwithoutanywarningsymptoms. Evenwhenwarningsymptomsarepresentbeforesyncope,lossof consciousnessusuallyoccurswithin10–20softheironset. Recov-eryistypicallypromptandcompletewithoutanyneedformedical interventionandwithoutanynewresidualneurologicfindings. Classificationofsyncope

Theclassificationofsyncopeismainlybasedontheunderlying mechanismsthatleadtothefinaleventoftransientglobal hypo-perfusion.Thediagnosticclassificationofthecausesofsyncope modifiedfromtheEuropeanSocietyofCardiology(ESC)syncope practiceguidelines[1]issummarizedinTable1.

Neurally-mediatedsyncope(alsotermedneuralreflexsyncope)

Thistypeofsyncopeincludesanumberofconditions.Themost importantandalsothemostcommonwithinthiscategoryis vaso-vagalsyncope.Thesecondmostcommoniscarotidsinussyncope (CSS)whichmostlyoccursintheelderlyandprimarilyinmen[3–6]. Carotidsinushypersensitivity(CSH)isaclinicalfindingelicitedby massagingthecarotidsinus.CSHshouldbedistinguishedfromCSS astheformerisaclinicalfindingandthelatterisaclinical mani-festation.CSSisonlydiagnosedifcarotidmassagecausessufficient bradycardia(usually>6s)and/orhypotensiontocause reproduc-tionofthepatients’symptoms.

Situationalsyncopeisathirdcategoryofreflexfaint;itincludes syncopetriggeredbyanyofanumberofactivitiessuchas: mic-turition,defecation,coughing,orswallowing.Theinitialevent(e.g. micturition)triggers [1,3]eithera slowheart rateordepressed vasculartone(orboth)that resultsinsufficient hypotensionto causetransientcerebralhypoperfusionandultimatetransient self-limitedepisodeoflossofconsciousness.Insomecases(e.g.cough syncope,trumpet-blowerssyncope),transientvenousobstruction duetoincreasedintra-thoracicpressuremaycontributetocerebral hypoperfusion.

Orthostatichypotension

Orthostaticsyncopeoccursasresultofthebody’sinabilityto maintainbloodpressureadequateforcerebralperfusionwhenthe individualmovestotheuprightposture,andwhichinturnresults inTLOC[1,7,8].Thechangeinposturefromlyingdowntoanupright positionresultsinshiftofasmuchas500–1000mLofbloodaway fromthechesttovenouscapacitancesystembelowthediaphragm; thisshiftinturnresultsindiminishedvenousreturntoheartand

Table1

ThediagnosticclassificationofthecausesofsyncopemodifiedfromtheEuropean SocietyofCardiologysyncopepracticeguidelines.

Reflex(neurally-mediated)syncope

Vasovagal:

-triggeredbyemotionaldistress -triggeredbyorthostaticstress Situational:

-cough,sneeze

-gastrointestinalstimulation -micturition

-others

Carotidsinussyncope

Orthostatichypotensionsyncope

Volumedepletion:

-inadequatefluidintake(hotweather),diarrhea,vomiting,etc. Drug-inducedorthostatichypotension:

-alcohol,vasodilators,diuretics,beta-adrenergicblockers Primaryautonomicfailure:

-pureautonomicfailure,multiplesystematrophy,Parkinson’sdiseasewith autonomicfailure,Lewybodydementia

Secondaryautonomicfailure:

-diabetes,amyloidosis,spinalcordinjuries

Cardiacsyncope(cardiovascular)

Arrhythmiaasprimarycause: Bradycardia:

-sinusnodedysfunction,atrioventricularconductionsystemdisease -implanteddevicemalfunction

Tachycardia:

-supraventricularincludingatrialfibrillation

-ventricular(idiopathicsecondarytostructuralheartdisease,ordueto channelopathies)

Structuraldisease:

-Cardiac:cardiacvalvulardisease,acutemyocardialinfarction/ischemia, hypertrophiccardiomyopathy,cardiacmasses(atrialmyxoma,tumors,etc.), pericardialdisease/tamponade,congenitalanomaliesofcoronaryarteries, prostheticvalvesdysfunction

-Othercardiovascular:pulmonaryembolus/hypertension,acuteaortic dissection

consequentreductionofcardiacfillingpressureandstrokevolume leadingtohypotensionandcerebralhypoperfusion.

Thehumanbodyhasphysiologicaldefensesagainstorthostatic hypotensive episodes. These include a reflex increase in heart rate,reflexarterialandvenousvasoconstriction(especiallyinthe splanchnicbedandlowerextremities),andneuroendocrine adjust-ments(activationofrenin–angiotensin–aldosterone system)[7]. Allofthesedefensespreventhealthyindividualsfromhavinga syn-copalevent.However,incertainsituationsthesedefensescouldbe undermined.Forexample,superimposedvolumedepletionorloss ofimpairedcardiacresponseduetochronotropicincompetence,or impairedreflexvasoconstrictionduetoautonomicdysfunctionor medications(e.g.beta-blockers,etc.),orlossofskeletalmuscletone whichiscommonintheelderly,maycausereducedvenousreturn. Theindividualasaresultofsyncopewillslumptogravitationally neutral positionwhich usually resultsin promptresumptionof cerebralperfusion.Physicalcounterpressuremaneuverssuchas leg-crossingandmusclestraininghavebeenfoundtobehelpful inincreasingvenousreturnbyenhancingmusclepumpactivity [1].

Syncopeduetocardiacarrhythmias

Cerebralhypoperfusionresultinginsyncopecanoccurdueto eitherbrady-ortachy-arrhythmias.Bradycardiaisthemore com-mon;in thiscategory,symptomatic hypotensioncanoccurasa resultofsinuspauses,high-gradeatrioventricularblockorasystole thatoccursattheterminationofanatrialarrhythmia(particularly attheendofanepisodeofatrialfibrillation).Cardiacpacemaker placementishelpfulinpreventingthesebradycardiacepisodes.

(3)

Bothsupraventricularandventriculartachyarrhythmiasmaybe responsiblefortriggeringsyncope.Neurally-mediatedhypotension mayalsocontributeinthesepatients.Patientswithautonomic dys-functionareatgreatestriskforarrhythmia-relatedsyncopesince protectivereflexesthataresupposedtobeineffecttocounterthe tachycardicstressareabsentoraretoosluggish.

The occurrence of syncope due to ventricular tachyarrhyth-mias in patients with poor left ventricular function or due to channelopathy(i.e.longQTsyndrome,catecholaminergic parox-ysmal ventriculartachycardia, Brugadasyndrome) is predictive of increasedrisk of mortality due tosudden cardiac death[9]. Therefore, these patientswhen identified need to bepromptly referredtocardiacelectrophysiologyforfurtherevaluation;most willwarrantplacementofanimplantablecardioverter defibrilla-tor(ICD)andsomemaybecandidatesformappingandablation therapy.

Syncopeduetostructuralcardiacdisease

Althoughinfrequent, syncope can occurasa resultof acute myocardialinfarctionorpulmonaryembolism.Reducedstroke vol-umeistheunderlyingmechanismforcerebralhypoperfusionin thesecases,althoughneural-reflexfactorsmaycontribute, espe-ciallyinthecaseofacutemyocardialischemia.Valvular/structural heartdisease(e.g.severeaorticstenosis, severemitralstenosis, and large left atrial myxoma) can cause syncope. The cerebral hypoperfusion inthesesituations is oftena resultof thedirect hemodynamicimpactofananatomicalanomalyaswellas neurally-mediatedreflexesorlackofthem.Inpatientswithsevereaortic stenosis,inappropriatevasodilatationwithexertionisanaccepted basisforsymptomatichypotensionresultinginsyncope[10].

Syncopesecondarytocerebrovascularcauses

Thebrainiswellprotectedwithmultiplebloodvessels feed-ingtheCircleofWillisandthereforetruesyncopealmostnever occursasadirectresultofcerebrovasculardiseasealone.However, althoughrare,atransientischemicattackinthevertebrobasilar dis-tributionmaycausesyncope.Thepresenceofposteriorcirculation symptomssuchaslossofbalanceandvertigomakestheseevents distinguishablefromothercausesofsyncope.

Stealsyndromeassociatedwithsubclavianstenosisisanother rareconditionthatcanresultinsymptomsofsyncope,dizziness, vertigo,ornystagmusespecially withvigorous useofipsilateral armmuscles.Syncopeasasolitarymanifestationofthiscondition isextremelyrare[11].

Syncopemimics

TLOCcanoccurinavarietyofsituationssuchasseizures, concus-sions,orintoxication.However,asnotedearlier,thesearenottrue syncopaleventsasthebasisisnotcerebralhypoperfusion.They arebeingmentionedhereduetothediagnosticconfusionthatthey maycause.

Psychogenic pseudosyncope (oftentermedpseudoseizureby neurologistsespeciallyifjerkymusclemovementsaccompanythe collapse)isthemostcommonconditioninthesyncopemimics cat-egory.Itmaybedifficulttodistinguishthese‘pseudo’episodesfrom true syncope. However, pseuodosyncope/pseudoseizures most oftenwilloccurseveraltimesadaywhichalmostneverhappens inthecaseoftruesyncope.Tilt-tabletestingmaybehelpfulnot onlyinidentifyingthesepatients,butalsomaypermitdiscussing thediagnosisfranklywiththesepatients[12].

TLOCcanalso occurin casesof cataplexy and certaintypes ofakinetic orminimallykineticseizures[13].In elderlypeople,

accidentalfallsmaycauseTLOCduetoconcussion.Thediagnostic confusion caused by the above-mentioned conditions can be clearedbycarefulattentiontohistorytaking,butanexperienced clinicianisusuallyessential.Whenuncertaintypersists,the place-mentofexternalorimplantablelooprecordersmaybehelpfulto distinguishtheseconditionsfromtruesyncope.

Riskstratificationofsyncope

Syncopeisachallengingsymptomforthefirstcontactprovider [usuallyanemergencydepartment(ED)orurgentcarephysician] todealwith.First,thepatienthasusuallyrecovered,sothereareno clearphysicalfindingstosuggestacause.Second,therearesomany possiblecausestoconsider.Third,thepatientorwitnesses(ifany) mayhavebeensosurprisedbytheunexpectedevent,thatdetailed historical findings are not clearly recollected. Finally, the time availableinanEDtoundertakeadetailedassessmentislimited.

Syncopeisnottypically alife-threateningconditionbyitself (althoughtheunderlyingcausemaybe).However,syncopemay resultinuntowardconsequencessuchasphysicalinjuryand dimin-ishedqualityoflife.Syncopemayalsobeanindicatorofpotentially life-threateningunderlyingconditions;forinstance,severe struc-turalheart diseasewithconsequentmalignant arrhythmiasand heartfailure.

Aconfidentdiagnosisofthecauseofasyncopeeventmayor maynotbemadeinEDorclinic.IncaseswherethecauseofTLOC isestablishedwithcertaintyduringinitialevaluation,the subse-quentcourseofactionisclear.However,moreoftenthediagnosisis unclearandtheresponsibleprovidersarefacedwiththedilemmaof choosingbetweenimmediatehospitalizationversustimely outpa-tientevaluation.Physicianshistoricallyhavefavoredaconservative courseofactionresultinginmanymorepatientsbeingadmittedto hospitalthaniswarranted.

The ESC Syncope Task Force provided guidelines for front-line providers to use for assessing patients presenting with TLOC/collapse/syncopeandtherebyarriveatadecisionbetween inpatientversusoutpatientevaluation.

Fig.1providesanoverviewofanapproachtoassessmentofa patientwhopresentswithTLOC/collapsebasedontheESCSyncope TaskForceGuidelines[1].

Atthepresenttime,despitetutoringthephysiciansinESC guide-lines,highadmissionratesappeartopersist(ashighas30–50%per

Fig.1.Flowchartfordiagnosticevaluationofpatientswhopresenttotheemergency department(ED)orclinicwithtransientlossofconsciousness(TLOC)/syncope. ModifiedafterRef.[1].

(4)

variousreports).Bywayofexample,Bartolettietal.[14]examined admissionratesamongpatientsreferredtoEDwithsyncope.The studywasbasedonESCguidelinesformanagementofsyncope[1]. Atotalof1124patientswereevaluatedand400(39.1%)ofthem metatleastonecriterionforadmissionperESCguidelinesand680 (60.9%)didnotmeetanycriteria.Theactualadmissionrateswere 89.3%amongpatientswithindicationand25.3%amongthose with-outanyindication.Thehighadmissionratesamongthelow-risk patientsareindicativeofphysicianconcernforpatientsafetyafter discharge.SimilarfindingswerenotedinEGSYS2study[15]where theadmissionratewasnotedtobeashighas39%despiteproviding expertonlineassistancetothefront-linephysicians.The unneces-saryinpatientadmissionoflow-riskpatientsnotonlyaddstothe costofcarebutalsomaynotimprovepatientsafetyordiagnostic outcomes.

RiskstratificationofTLOC/syncopepatientshasbeenthe sub-jectofseveralrecenttrialswiththeobjectivebeingabletoderive effectivecriteriatohelpchoosebetweeninpatientadmissionand outpatientsyncopeclinicreferral[16].Themostimportant objec-tivesofrisk-stratificationstudiesaretoassesstheimmediateor short-term(1weekto1month)andlonger-term(approximately1 year)riskof:

1)Deathorlife-threateningevents.

2)Recurrenceofsyncopalevents,whichinturnmayleadto phys-icalinjury,disability,ordiminishedqualityoflife.

Althoughaconsensusrisk-stratificationtoolisnotyetavailable, suchatool-setwouldhopefullyhelpEDorclinicphysicians deter-minetheimmediateriskofadverseeventsandifriskisdeemedto behigh,itshouldpromptthephysiciantoadmittothehospitalfor furtherevaluation[16].Incaseswheretheriskisfelttobe inter-mediate,oneshouldconsiderplacementofthepatientinasyncope observationunitifavailable,aswasdoneintheSEEDSstudy[17]. Intheabsenceofimmediateorshort-termriskbasedonsucha tool,thepatientsmaybereferredforoutpatientevaluation prefer-ablyinaclinicdedicatedforevaluationofpatientswithsyncopeor TLOC.Insomesituations,thepresenceofriskfactorsforincreased long-termriskoflife-threateningevents,patientsmayneed hospi-talizationforfurtherassessment.Severalclinicalstudiesfocuson assessmentofshort-termandlong-termriskfactorstoprovidethe neededguidance.

Short-termorimmediaterisk

Theshort-termorimmediateriskofadverseeventsinthe subse-quent30daysafterinitialpresentationhasbeenthefocusofseveral clinicalstudies(Table2).Thefindingsaresummarizedbrieflyhere andinTable2.

1)SanFranciscorule

Theriskfactorsidentifiedtobepredictiveofincreasedriskof adverseeventswithinthe7daysincluded[18]:

1)An abnormal electrocardiogram (ECG) (i.e. new rhythm changesornon-sinusrhythm).

Table2

Short-termrisk(1weekto1month).

Study Clinicalmarkers

SanFrancisco[18] AbnormalECG,lowbloodpressure,CHF,SOB, hematocrit<30%

Roserule[19] AbnormalECG,elevatedBNP,chestpain,fecalblood STePS[21] AbnormalECG,trauma,nowarning,malegender ECG,echocardiography;CHF,congestiveheartfailure;SOB,shortnessofbreath;BNP, brainnatriureticpeptide.

2)Systolicbloodpressure<90mmHg. 3)Hematocrit<30%.

4)Congestiveheartfailure(CHF)(eitherpresentatthetimeof initialpresentationorahistoryofCHF).

Theadverseeventsincludedtheoccurrenceofdeath, myocar-dial infarction, malignant arrhythmia, pulmonary embolism, stroke,subarachnoid hemorrhage,significant hemorrhage or otherseriouseventswhichrequiredreturntoEDand subse-quenthospitalization.

2)TheRoserule

Thiswasan ED-basedsingle center studyfromEdinburgh UKthat wasdesigned toidentify therisk factorspredictive ofanadverseeventwithin1-monthafterinitialpresentation to ED with syncope [19]. The adverse events were defined astheoccurrence ofdeath, acutemyocardial infarction, life-threateningarrhythmia,beingdiagnosedwithanyarrhythmia whichrequiredimplantationofacardiacpacemakeror defibril-latorwithinonemonth,pulmonaryembolism,cerebrovascular accident, hemorrhage or profound anemia requiring blood transfusion,andany returnstoEDwithin onemonth which requiredurgentsurgicalorendoscopicintervention.The find-ingsthatpredictedthelikelihoodofabove-mentionedadverse outcomesincluded:

1)Brainnatriureticpeptide>300pg/mL. 2)Stoolpositiveforoccultblood.

3)Oxygensaturation<94%onroomaironinitialpresentation. 4)Hemoglobin<90g/L.

5)Chestpainatthetimeofsyncope.

6)Bradycardia(heartrate<50beatsperminute).

Ofthestudypopulation,7.1%metwithanendpointattheend ofonemonth.ThesensitivityandspecificityofRoserulewere estimatedtobe87.2%and65.5%,respectively.

3)TheBostonstudy

Thisstudyincludedatotalof293patientswhowerefollowed for30daysaftertheirinitialpresentationtoEDwithsyncope, lookingforoccurrenceofadverseoutcomessuchasdeath, seri-ousillnessthatrequiredhospitalizationoracuteinterventions [20].

Sixty-eight(23%)patientsmetwithanadverseoutcome.The riskfactorsidentifiedinthisstudythatpredictedthelikelihood ofanadverseeventincludedthefollowing:

1)Acutecoronarysyndrome(ACS). 2)Conductionsystemdisease. 3)Historyofcardiacdisease. 4)Valvularheartdisease. 5)Familyhistoryofsuddendeath. 6)AbnormalvitalsignsinED. 7)Volumedepletion.

8)Primarycentralnervoussystemevent.

Thesensitivityandspecificityofthisstudyare97%and62%, respectively.

4)STePSstudy

A total of 676 patients were included in this study after screeningatotalof2700patientswithpresumedsyncope[21]. Theadverseoutcomeswithin10daysofinitialpresentationwith syncopewereassessed.Thestatisticallysignificantriskfactors predictiveofadverseoutcomeswere:

1)Age>65years. 2)Malegender.

3)Structuralheartdisease. 4)Heartfailure.

5)Trauma.

6)Absenceofsymptomsofimpendingsyncope. 7)AbnormalECG.

Thestudy,however,hadalowpositivepredictivevalueofonly 11–14%duetoalowrateofadverseevents.

(5)

Theabove-mentionedstudiestriedtoidentifytheriskfactors thatpredictedthelikelihoodofanadverseoutcome.Theriskfactors identifiedinthesestudiestendedtohaveahighsensitivitybut notspecificity.However,toidentifythehigh-riskpatientswhowill needprompthospitalizationuponinitialevaluation,theknowledge fromthesestudiescanbesummarizedasfollows.

High-riskmarkersofshort-termadverseoutcomes

Thefollowingriskfactorswerenotedtobeconsistently asso-ciatedwithincreasedriskofadverseoutcomesinallthestudies andwhenidentifiedaspartoftheinitialevaluationalmostalways resultinhospitalizationofthepatient.

1)ACSorsymptomssuggestiveofACSassociatedwithsyncopei.e. chestpainorshortnessofbreath.

2)EvidenceofCHFatthetimeofpresentationorahistoryofit. 3)Historyofstructuralheartdisease.

4)AbnormalECG. 5)Anemia.

6)Hemodynamicinstability.

TheESCguidelinesonmanagementofsyncopelistedthecriteria forhospitalizationofpatientspresentingwithsyncope. Hospital-izationofpatientsisadecisionthatshouldbemadecarefullyasone shouldbemindfulofnotonlypatientinconvenienceandanxiety butalsoahighlevelofavoidablehealthcareexpenditure.

Long-termrisk

Long-termriskisdefinedastheriskofanadverseeventinone yearorlongerafterinitialpresentationwithsyncope.Several stud-ieshaveattemptedtoestablishthelong-termriskfactors;several ofthesearesummarizedbelow.Table3summarizesthefindings fromthesestudies.

1)Martinetal.

Thisprospectivecohort studyfromtheUniversityof Pitts-burghconsistedoftwogroups [22].Thefirst groupincluded 252patientswithsyncope whoweremade apartof a risk-assessmentscheme(derivationcohort).Inthisgroup,thedata fromthepatient’shistory,physicalexamination,andECGdone intheEDwereusedtoidentifypredictorsofarrhythmiasor mor-talitywithinthefirstyear.Thesecondgroupconsistedof374 patientswithsyncopeinordertovalidatethesystem(validation cohort).Theobjectivewastoidentifythepredictorsofadverse outcomes(deathorseriousarrhythmias)at1-yearfollow-up. Fourmultivariateriskfactorswereidentifiedinthisstudy: 1)Abnormal ECG [odds ratio (OR) 3.2, 1.6–6.4] defined as

rhythm abnormalities, conduction disorders, hypertrophy, oldmyocardialinfarction,oratrioventricularblock.

2)Historyofventriculararrhythmia(OR4.8,1.7–13.9). 3)Historyofcongestiveheartfailure(OR3.1,1.3–7.4). 4)Age>45years(OR3.2,1.3–8.1).

Table3

Longer-term.

Study Clinicalmarkers

Martinetal.[22] AbnormalECG,CHF,SOB,ventriculararrhythmia,age >45years

OESILscore[23] AbnormalECG,age>65years,historyofcardiovascular disease,nowarning

EGSYS[24] Palpitationbeforeevent,abnormalECGorheart disease,syncopeduringeffort,syncopesupine ECG,echocardiography;CHF,congestiveheartfailure;SOB,shortnessofbreath.

Inpatientswithoutanyriskfactors,adverseeventswhichare definedasdeathorarrhythmiasoccurredin7.3% ofpatients inthederivationcohort and4.4%inthevalidationcohort.In patientswiththree tofourriskfactors,theabove-mentioned adverseeventsoccurredin80.4%ofpatientsinthederivation cohortand57.6%inthevalidationcohort.

2)STePSstudy

Atotalof676patientswereincludedinthisstudy[21]. Long-termadverseoutcomesweredefinedasdeathortheneedfor majortherapeuticprocedures.Adverseoutcomesoccurredin 9.3%ofthestudypopulationwhichincluded40(6%)deathsand 22patientsrequiringmajortherapeuticprocedures.

Five risk factors identified through a multivariate analysis wereassociated withadverseoutcomesin this study,which included:

1)Age>65years. 2)Historyofneoplasm. 3)Cerebrovasculardisease. 4)Structuralheartdisease. 5)Ventriculararrhythmia.

Mortalitywasnotedtobehigher(p<0.05)at1yearinpatients whowere admittedtothe hospital(14.7%) compared tothe patientswhoweredischarged(1.8%).

3)OESILstudy

Theriskfactorsidentifiedtobepredictiveof1-yearmortality inthisstudy[23]included:

1)Age>65years.

2)Historyofcardiovasculardisease. 3)Lackofprodromes.

4)AbnormalECGdefinedasrhythmabnormalities,conduction disorders,hypertrophy,oldmyocardialinfarction,possible acuteischemia,oratrioventricularblock.

One-yearmortalityinthisstudyincreasedprogressivelyfrom 0%inpatientswithnoneoftheabove-mentionedriskfactors,to approximately57%inpatientswith4riskfactors.

4)EGSYSscore

ThesixriskfactorsidentifiedintheEGSYSstudythatwere predictiveofadverseoutcomes[24]are:

1)Historyorevidenceofischemicheartdisease. 2)Valvularheartdisease.

3)Cardiomyopathy. 4)Congenitalheartdisease. 5)CHF.

6)Abnormal ECG (sinus bradycardia, atrioventricular block greaterthanfirstdegree,bundlebranchblock,acuteorold myocardialinfarction,supraventricularorventricular tachy-cardia, evidence of left or right ventricular hypertrophy, ventricularpreexcitation,longQT,orBrugadapattern). Themortalityat2yearswasnotedtobe2%inpatientswitha score<3and21%forascore>3.

Riskstratificationbasedoncardiacversusnon-cardiac causesofsyncope

Syncopefromacardiaccausehasbeennotedtobeassociated with both short- and long-term risk of adverse outcomes.The comparison ofmorbidityand mortalityinpatientswithcardiac syncopeandnon-cardiacsyncopehasbeenthesubjectofseveral studies.

1)Soteriadesetal.

Atotalof7814patientswereincludedinthisstudywhich evaluatedtheincidenceand prognosisamong participantsin theFraminghamheartstudyfrom1971to1998[25].Syncope occurredin822patients.Cardiaccausewasconsideredbythe

(6)

investigatorstobetheetiologyin9.4%andvasovagalin21.2%.In 36.6%thecauseofsyncoperemainedunknown.The multivari-atehazardratiosformortalityfromanycauseandstrokewere notedtobesignificantlyhigherinpatientswithpresumed car-diaccauseofsyncopewhencomparedtopatientswithsyncope fromothercauses.Thestudy,however,hadinherentweakness ofitsdiagnosticclassificationmainlyduetothelimitednature ofcollectedclinicalinformation.

2)Kapooretal.

Thisstudyassessedthemorbidityandmortalityattheendof5 yearsinatotalof433patientswhopresentedwithsyncope[26]. Initialhistory,physicalexamination,ECG,andprolongedcardiac monitoringwerehelpfulinassigningthecauseofsyncope,but onlyin22%ofthestudypopulation.Themortalityattheendof 5yearswasnotedtobesignificantlyhigher(50.5%)inpatients withcardiaccauseofsyncopewhencomparedtopatientswith non-cardiacorunknowncauseofsyncope(24.1%).Inaddition, theincidenceofsuddencardiacdeathwasnotedtobe signifi-cantlyhigher(33.1%)inpatientswithcardiaccauseofsyncope whencomparedtonon-cardiac(4.9%)orunknowncause(8.5%). 3)Ungaretal.

This recent study which included a relatively older set of patients(age66+20years)examinedtheriskofcardiovascular mortalityamongthepatientsenrolledinEvaluationof Guide-linesinSyncopeStudy2(EGSYS2)study[27].Atotal of380 patientswereincludedinthisstudywhichexaminedboth short-term(1month)andlong-term(2years)mortality.Atotalof35 (9.2%)deathsoccurredattheendof2years.Thedeathswere significantlyhigher(82%)inpatientswhowereolderandwho hadcardiacriskfactors,abnormalECGorahistoryofstructural heartdiseaseandsustainedinjuries relatedtosyncopewhen comparedtopatientswithoutabnormalECGorstructuralheart disease(3%).

4)Numerosoetal.

Inthisrecentstudyatotalof200patientspresentingwith syn-copewerefollowedtoevaluateincidenceofbothshort-term (1month)andlong-term(1year)adverseeventswhichwere definedasdeath,recurrenceofsyncope,cardiovascularevents, andmajorprocedures[28].Cardiacsyncopewasassociatedwith both greatershort-andlong-termoccurrence ofatleastone adverseevent.

Issyncopeamarkerofincreasedriskofcardiovascular morbidityandmortality?

Thisimportant question remains unresolved. A large recent population-basedstudy from Denmark [29] suggested that the occurrence of syncopein patientswithout anyprior history of co-morbiditiesmayconferanincreasedriskofcardiovascular mor-bidity and mortality. A total of 37,017 (median age 47 years) patientsadmittedtohospitalwithafirstsyncopeeventbetween 2001and 2009 were identified fromnationwide registries and approximatelyfivetimesthenumber(n=185,085)werechosen fromtheDanishpopulationascontrolsubjects(withoutsyncope) whowerematchedforageandsex.MultivariableCoxregression analysisdemonstrated a significantlyhigher all-causemortality andcardiovascularhospitalizationandeventrate(recurrent syn-cope,stroke,andplacementofICDorpacemaker)inpatientswith syncopewhencomparedtothecontrolsubjectswithoutsyncope. Thestudydidhaveamajorlimitationinthatthestudy popula-tionwashospitalizedpatientswithsyncopeandtheothercauses necessitatinghospitalizationwerenotcontrolled.Thefindingsin thisstudyhoweverdoemphasizetheimportanceofcarefulinitial evaluationofallpatientswithsyncopeandtheneedfordiligent riskstratification.

Table4

CriteriaforhospitalizationorintensiveevaluationbasedonEuropeanSocietyof Cardiology2009guidelines.

Severestructuralheartdiseaseorcoronaryheartdisease:

-Heartfailure

-Lowleftventricularejectionfraction -Previousmyocardialinfarction

Clinicalfeaturessuggestiveofarrhythmicsyncope:

-Syncopeinsupineposition -Syncopeduringexertion

-Palpitationsassociatedwithsyncope -Familyhistoryofsuddencardiacdeath

Electrocardiographicfindingssuggestingarrhythmicsyncope:

-Nonsustainedventriculartachycardia

-Bifascicularblock(leftbundlebranchblockorrightbundlebranchblock combinedwithleftanteriorofposteriorfascicularblock)

-OtherintraventricularconductionabnormalitieswithQRScomplex duration>120ms

-Inadequatesinusbradycardia(<50bpm)orsinoatrialblockinabsenceof negativechronotropicmedications(e.g.beta-blockersor

nondihydropyridinecalciumchannelblockers)orphysiologicbradycardia associatedwithphysicaltraining

-Pre-excitedQRScomplex -ProlongedorshortQTinterval

-RightbundlebranchblockpatternwithSTelevationinleadsV1–V3 (Brugadapattern)

-NegativeTwavesinrightprecordialleads,epsilonwavesandventricular latepotentialssuggestiveofarrhythmogenicrightventriculardysplasia

Importantco-morbidities:

-Severeanemia -Electrolyteabnormalities

Conclusion

Understandingthevariouscausesofsyncopeand differentiat-ingsyncopefromothercausesofTLOCarecriticalelementsinthe assessmentof patientswhopresent with‘collapse’. Inaddition, riskstratificationisanindispensablepartoftheinitialevaluation ofpatientspresentingwithsyncopeasitprovidesanopportunity to identify and protect the patients at immediate risk of life-threateningeventsbyprompthospitalization.Riskstratification, whenoptimal, alsoofferstheopportunitytoavoidunnecessary hospitalizationoflow-riskpatients,therebyreducingthe health-careexpenditure.Consequently,theneedtodevelopoptimalrisk assessmenttoolsandtrainfront-lineprovidersintheirusecannot beover-emphasized.

Atthepresenttime,whileaconsensusrisk-stratification instru-mentremainsinevolution, short-termriskstratificationstudies providecompellingevidencetohospitalizesyncopepatientswith a suspected cardiac cause (structural or arrhythmic). All the long-termstudiesunequivocally emphasizetheneedforcareful evaluationandmanagementofunderlyingheartdiseaseinthese patients.

Currently,the2009ESCTaskForceGuidelinesformanagement ofsyncopeprovideausefulandrelativelyup-to-datesummaryof currentcriteriaforhospitalization[1](Table4).Theseguidelines stronglyencouragethedevelopmentwithinmajormedical cen-tersofdedicated‘syncopeclinics,’staffedbyamultidisciplinary teamofinterestedmedicalprofessionals (cardiology,neurology, internalmedicine,psychiatry).Suchunitsmayactasaresourcefor acceleratingeffectiveassessmentofin-hospitalpatients,buteven moreimportantlyprovideareadilyaccessiblesitefortimely outpa-tientevaluationsofsyncope/collapsepatientswhodidnotrequire urgenthospitalization.

Acknowledgment

Thisworkwassupportedinpartbya grant fromtheEarlE BakkenFundforHeart–BrainResearchattheMinnesotaMedical Foundation.

(7)

References

[1]TaskForcefortheDiagnosisandManagementofSyncope,EuropeanSociety ofCardiology(ESC),EuropeanHeartRhythmAssociation(EHRA),HeartFailure Association(HFA),HeartRhythmSociety(HRS),MoyaA,SuttonR,AmmiratiF, MassinM,PepiM,PezawasT,RuizGranellR,SarasinF,UngarA,vanDijkJG, etal.Guidelinesforthediagnosisandmanagementofsyncope(version2009). EurHeartJ2009;30:2631–71.

[2]BlancJJ,BendittDG.Syncope:definition,classificationandmultiplepotential causes.In:BendittDG,BlancJJ,BrignoleM,SuttonRS,editors.The evalua-tionandtreatmentofsyncope.Ahandbookforclinicalpractice.Elmsford,NY: FuturaBlackwell;2003.p.3–10.

[3]VanDijkJG,ThijsRD,BendittDG,WeilingW.Aguidetodisorderscausing transientlossofconsciousness:focusonsyncope.NatRevMed2009;5:438–48.

[4]RyanDJ,NickS,ColetteSM,RoseanneK.Carotidsinussyndrome,should wepace?Amulticentrerandomizedcontrolledtrial(SAFEPACE2).Heart 2010;96:347–51.

[5]ParrySW,SteenN,BextonRS,TynanM,KennyRA.Pacinginelderlyrecurrent fallerswithcarotidsinushypersensitivity:arandomizeddouble-blind placebo-controlledcrossovertrial.Heart2009;95:405–9.

[6]KredietCT,ParrySW,JardineDL,BendittDG,BrignoleM,WielingW.Thehistory ofdiagnosingcarotidsinushypersensitivity:whyarethecurrentcriteriatoo sensitive?Europace2011;13:14–22.

[7]MathiasCJ.Autonomicdiseases:clinicalfeaturesandlaboratoryevaluation.J NeurolNeurosurgPsychiatry2003;74(Suppl.3):iii31–41.

[8]FreemanR, WielingW,AxelrodFB,BendittDG, BenarrochE,BiaggioniL, CheshireWP,ChelimskyT,CortelliP,GibbonsCH,GoldsteinDS,Hainsworth R,HilzMJ,JacobG,KaufmannH,etal.Consensusstatementonthe defini-tionoforthostatichypotension,neurallymediatedsyncopeandthepostural tachycardiasyndrome.ClinAutonRes2011;21:69–72.

[9]OlshanskyB,PooleJE,JohnsonG,AndersonJ,HellkampAS,PackerD,MarkDB, LeeKL,BardyGH,SCD-HeFTInvestigators.Syncopepredictstheoutcomeof cardiomyopathypatients:analysisoftheSCD-HeFTstudy.JAmCollCardiol 2008;51:1277–82.

[10]SchwartzLS,GoldfischerJ,SpragueGJ,SchwartzSP.Syncopeandsuddendeath inaorticstenosis.AmJCardiol1969;23:647–58.

[11]Chan-TackKM.Subclavianstealsyndrome:ararebutimportantcauseof syn-cope.SouthMedJ2001;94:445–7.

[12]PetersenME,WilliamsTR,SuttonR.Psychogenicsyncopediagnosedby pro-longedhead-uptilttesting.QuartJMed1995;88:209–13.

[13]KovacS,DiehlB.Atonicphenomenainfocalseizures:nomenclature,clinical findingsandpathophysiologicalconcepts.Seizure2012;21:561–7.

[14]BartolettiA,FabianiP,AdrianiP,BaccettiF,BagnoliL,BuffiniG,CappellettiC, CecchiniP,GianniR,LavacchiA,TicaliPF,SantoroGM.Hospitaladmissionof patientsreferredtotheEmergencyDepartmentforsyncope:asingle-hospital prospectivestudybasedontheapplicationoftheEuropeanSocietyof Cardiol-ogyGuidelinesonsyncope.EurHeartJ2006;27:83–8.

[15]BrignoleM,UngarA,CasagrandaL,GliziaM,LunatiM,AmmiratiF,DelRosso A,SasdelliM,SantiniM,MaggiR,VitaleE,MorrioneA,FranceseM,Vecchi

MR,GiuliS,etal.Prospectivemulticentresystematicguideline-based manage-mentofpatientsreferredtothesyncopeunitsofgeneralhospitals.Europace 2010;12:109–18.

[16]BendittDG,CanI.Initialevaluationof“syncopeandcollapse”theneedfora riskstratificationconsensus.JAmCollCardiol2010;55:722–4.

[17]ShenWK,DeckerWW,SmarsPA,GoyalDG,WalkerAE,HodgeD,TrustyJM, BrekkeKM,JahangirA,BradyPA,MungerTM,GershBJ,HammillSC,FryeRL. SyncopeEvaluationintheEmergencyDepartmentStudy(SEEDS).A multidis-ciplinaryapproachtosyncopemanagement.Circulation2004;110:3636–45.

[18]QuinnJV,StiellIG,McDermottDA,SellersKL,KohnMA,WellsGA.Derivation oftheSanFranciscoSyncopeRuletopredictpatientswithshort-termserious outcomes.AnnEmergMed2004;43:224–32.

[19]ReedMJ,NewbyDE,CoullAJ,PrescottRJ,JacquesKG,GrayAJ.TheROSE(risk stratificationofsyncopeintheemergencydepartment)study.JAmCollCardiol 2010;55:713–21.

[20]Grossman SA, Fischer C, Lipsitz LA, Mottley L, Sands K, Thompson S, ZimetbaumP,ShapiroNI.Predictingadverseoutcomesinsyncope.JEmerg Med2007;33:233–9.

[21]CostantinoG,PeregoF,DipaolaF,BorellaM,GalliA,CantoniG,Dell’OrtoS,Dassi S,FilardoN,DucaPG,MontanoN,FurlanR,STePSInvestigators.Short-and long-termprognosisofsyncope,riskfactors,androleofhospitaladmission:results fromtheSTePS(Short-TermPrognosisofSyncope)study.JAmCollCardiol 2008;51:276–83.

[22]MartinTP,HanusaBH,KapoorWN.Riskstratificationofpatientswithsyncope. AnnEmergMed1997;29:459–66.

[23]ColivicchiF,AmmiratiF,MelinaD,GuidoV,ImperoliG,SantiniM,OESIL (OsservatorioEpidemiologicosullaSincopenelLazio)Study Investigators. Developmentandprospectivevalidationofariskstratificationsystemfor patientswithsyncopeintheemergencydepartment:theOESILriskscore.Eur HeartJ2003;24:811–9.

[24]DelRossoA,UngarA,MaggiR,GiadaF,PetixNR,DeSantoT,MenozziC, BrignoleM.Clinicalpredictorsofcardiacsyncopeatinitialevaluationin patients referredurgently to a generalhospital: the EGSYS score. Heart 2008;94:1620–6.

[25]SoteriadesES,EvansJC,LarsonMG,ChenL,BenjaminEJ,LevyD.Incidenceand prognosisofsyncope.NEnglJMed2002;347:878–85.

[26]KapoorWN.Evaluationandoutcomeofpatientswithsyncope.Medicine (Bal-timore)1990;69:160–75.

[27]UngarA,DelRossoA,GiadaF,BartolettiA,FurlanR,QuartueriF,Lagi A, MorrioneA,MussiC,LunatiM,DeMachiG,DeSantoT,MarchionniN,Brignole M,EvaluationofGuidelinesofSyncopeStudy2Group.Earlyandlateoutcome oftreatedpatientsreferredforsyncopetoemergencydepartment:theEGSYS 2follow-upstudy.EurHeartJ2010;31:2021–6.

[28]NumerososF,MossiniG,LippiG,CervellinG.Evaluationofthecurrent progno-sticroleofcardiogenicsyncope.InternEmergMed2013;8:69–73.

[29]RuwaldMH, Hansen ML,Lamberts M,Hansen CM,Vinther M,Køber L, Torp-PedersenC,HansenJ,GislasonGH.Prognosisamonghealthy individ-ualsdischargedwith a primary diagnosisof syncope.J AmColl Cardiol 2013;61:325–32.

References

Related documents

in 2965 subjects of the Framingham Offspring Study Co- hort and found that the prediction of cardiovascular disease became better after addition of maximum intima-media thickness

Methods: A Markov cycle tree evaluated using cohort simulation was developed utilizing Framingham estimates of cardiovascular risk, 1998 United Kingdom mortality data, the

Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian

The aims of the present study were to develop and to validate a CDR with history, examination, electrocardiogram (ECG), and biochemical markers to predict 1-month serious outcome

BMC Proceedings Proceedings Classification tree for detection of single nucleotide polymorphism (SNP) by SNP interactions related to heart disease Framingham Heart Study Li Yao1,

FHS: Framingham Heart Study; PROCAM: Prospective Cardiovascular Munster Score; WHO/ISH: World Health Organization/ International Society of Hypertension; SCORE: Systemic Coronary

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung,

A cross- validation of risk scores for coronary heart disease mor- tality based on data from the Glostrup Population Studies and Framingham Heart Study. Primary Prevention of